CAMPBELL, CA - (NewMediaWire) - November 05, 2015 - Friendable, Inc. (OTC PINK: FDBL) (the "Company") is pleased to announce that it has launch a multi-channel advertising and social media campaign to increase market awareness for the Friendable …
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that Samsung Bioepis will present new Phase 3 clinical data for three investigational immunology biosimilar candidates at the American …
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), announced today that four abstracts highlighting the potential of CB-839, the Company’s novel, orally bioavailable glutaminase inhibitor for the …
Christine Lagarde Managing Director, International Monetary Fund New York Fed, November 5, 2015 As prepared for delivery Introduction President Dudley—thank you for your generous introduction. I would also like to thank the staff of the New York Fed for …
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that Samsung Bioepis will present new Phase 3 clinical data for three investigational immunology biosimilar candidates at the American …
NEWTON, Mass., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that 17 abstracts, including 5 oral presentations and 12 posters describing the activity of its oncology …
SAN DIEGO, Nov. 5, 2015 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders, announced today that it …
NEWTOWN, Pa., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that an abstract relating to the …
PRINCETON, N.J., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today announced that the Company will present at the Jefferies Autumn 2015 Global Healthcare …
MENLO PARK, Calif., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that three abstracts describing clinical and non-clinical data on imetelstat have been accepted for presentation at the 57th American Society of …
- Highly potent, specific, and oral factor D inhibitors effectively block hemolysis of paroxysmal nocturnal hemoglobinuria (PNH) cells and mitigate the accumulation of C3 fragments – - Inhibitory effect against atypical hemolytic uremic syndrome (aHUS) …
First-in-Human Clinical Trial to Prevent Acute Graft-versus-Host Disease and Severe Infections Planned for 2016 Poster Presentations to Highlight Preclinical Findings and Potential Therapeutic and Pharmacoeconomic Value Propositions in HCT SAN DIEGO, Nov. …
SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today announced that preclinical research on G100, Immune Design's intratumoral TLR4 …
NEW YORK and MEXICO CITY, Nov. 5, 2015 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) and Bolsa Institucional de Valores (BIVA), announced today that BIVA will implement Nasdaq's X-stream Trading technology to run Latin America's newest exchange. X- …
PHILADELPHIA and DUBAI, United Arab Emirates, Nov. 5, 2015 (GLOBE NEWSWIRE) -- Hill International (NYSE:HIL), the global leader in managing construction risk, announced today the promotion of four executives to the position of Senior Vice President with …
WOODBRIDGE, N.J., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Lime Energy Co. (Nasdaq:LIME), today announced that it will file its 2015 third quarter financial statements after the market close on Thursday, November 12th. The same day Lime Energy will hold a …
SANTA MONICA, Calif., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Kite) (Nasdaq:KITE) today announced upcoming presentations related to KTE-C19, Kite's lead product candidate, that will take place at the 57th ASH Annual Meeting in Orlando, …
LAS VEGAS, Nov. 5, 2015 (GLOBE NEWSWIRE) -- Nevada Gold & Casinos, Inc. (NYSE MKT:UWN) today announced that the Nevada Gaming Control Board has recommended approval of its application for a nonrestricted gaming license in conjunction with its pending …
DENVER, Nov. 5, 2015 (GLOBE NEWSWIRE) -- Air Methods Corporation (NASDAQ:AIRM), the global leader in air medical transportation, today announced that it has entered into a definitive agreement to acquire Tri-State Care Flight ("Tri-State") for $ …
NASHUA, N.H., Nov. 5, 2015 (GLOBE NEWSWIRE) -- iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the …
03 days 23:28:31
